Are you working on a big bang company?
- Details
- Category: Development
Alcon expands leadership position in treating glaucoma through acquisition of Transcend Medical, Inc.
- Details
- Category: Novartis
Diabetes drug may prevent recurring strokes
- Details
- Category: Research
U.S. FDA grants Breakthrough Therapy Designation for Roche's investigational medicine ocrelizumab in primary progressive multiple sclerosis
- Details
- Category: Roche
eyeforpharma Barcelona 2016 conference
- Details
- Category: Events
eyeforpharma Barcelona will set the vision for your 2020 plans. With 120% attendee growth you can join 1000+ industry leaders in commercial excellence, patient engagement and innovation at the unmissable pharma-stakeholder summit. As your customer takes charge this meeting will enable you take the steps you need to become their partner of choice.
'Beiging' white fat cells to fight diabetes
- Details
- Category: Research
Bristol-Myers Squibb and Dana-Farber Cancer Institute enter into a collaboration agreement
- Details
- Category: Bristol-Myers Squibb
Combination drug targeting opioid system may help relieve treatment-resistant depression
- Details
- Category: Research
Drug development crisis linked to bad technology choices, experts argue
- Details
- Category: Development
UCB and Baylor College of Medicine launch strategic alliance in neurodegeneration
- Details
- Category: UCB